PaxMedica, Inc. (PXMD)
Develops suramin-based drugs to treat autism, chronic fatigue, and other neurologic conditions.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+400.0%
The outlook
PXMD trades near its 52-week low with a StockGlow score of 9/100, indicating a bearish lean. The stock sits well below both its 50- and 200-day moving averages, reflecting weak recent momentum. Analyst coverage appears unavailable for this micro-cap name.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$63,132
52-wk high
$0.02
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
0.0